DeutschNewstral
Article
Forbes on 2024-05-10 15:41
Novavax Shares Surge Over 140% After $1.4 Billion Covid Shot Deal With Sanofi
Related news
- INovavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 lossesinvezz.com
- MNovavax inventory jumps on Sanofi Covid vaccine dealmvtelegraph.com
Sanofi SA: Sanofi shares fall on lower profit outlookFinancial Times- MGSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as 'best-case scenario'3 min readmarketwatch.com
Japan approves Novavax as 4th COVID vaccine amid new surgestaradvertiser.com- FNovo Nordisk shares drop 17% but Sanofi gaining 5%ft.com
- MRegeneron, Sanofi halt trial for experimental coronavirus drug, shares fallmarketwatch.com
Trump Media Shares Surge Againbreitbart.com
Novavax shares jump on positive news of flu vaccine trialbizjournals.com- MNovavax shares plummet more than 80% after vaccine trial failsmarketwatch.com
- Novavax shares jump on news of narrowed first-quarter lossesbizjournals.com
- Novavax shares up big again. What's moving the needle?bizjournals.com
- Novavax shares fall on RSV, NanoFlu vaccine updatesbizjournals.com
Tesla shares surge after record vehicle deliveriesNew York Post- BGSK, Sanofi, Haleon Shares Soar as Federal Judge Tosses Zantac Suits3 min readbarrons.com
- GGlobal Small Lymphocytic Lymphoma Drug Market Shares of Main Players 2022|Sanofi, Pfizer, Bayergalleonnews.com
- Shares Of SPAC Behind Trump Social Media Company Jump 140%Forbes
- MSanofi, Regeneron shares Pop, information exhibits bronchial asthma drug Dupixent can deal with COPDmvtelegraph.com
- BModerna and Novavax Shares Rebound After Slumping on Pfizer's Outlook1 min readbarrons.com